FBI RAIDS Hidden US Biolab — Terrifying Discovery Inside

Gloved hands holding evidence swab in laboratory.

FBI agents raided a Las Vegas home tied to the same Chinese national behind an illegal California biolab that distributed hundreds of thousands of misbranded medical tests, exposing yet another gaping hole in America’s biosecurity under the previous administration’s lax oversight.

Story Snapshot

FBI raided a northeast Las Vegas home owned by individuals linked to a notorious 2023 California illegal biolab operation involving misbranded COVID-19 and HIV tests
The property owners, Jia Bei Zhu (using multiple aliases) and Zhaoyan Wang, previously ran unauthorized facilities that housed 1,000 genetically engineered mice and distributed fraudulent diagnostic test kits
Federal agents discovered refrigerators containing vials of unknown biological liquids at the Las Vegas residence, escalating what began as a code violation to a Joint Terrorism Task Force investigation
Zhu faces federal charges for lying to the FDA and manufacturing misbranded medical devices during the COVID-19 pandemic, yet continued operating across state lines

Pattern of Deception Across State Lines

Jia Bei Zhu, a 62-year-old Chinese national operating under aliases including David He, Jesse Zhu, and Qiang He, orchestrated a multi-state scheme that exploited pandemic demand for medical testing. Between December 2020 and March 2023, Zhu and his business partner Zhaoyan Wang manufactured and distributed hundreds of thousands of misbranded COVID-19, HIV, pregnancy, and urinalysis test kits through shell companies Universal Meditech Inc. in Fresno and Prestige Biotech Inc. in Reedley, California. The Department of Justice arrested Zhu in October 2023 for making false statements to the FDA about his identity and role in the operation.

The Las Vegas property, owned through an LLC linked to both Zhu and Wang, became the focus of federal attention on February 1, 2026, when FBI agents and Las Vegas Metropolitan Police executed a search warrant. What started as a routine code-violation call escalated rapidly when authorities discovered evidence suggesting potential biological materials on site. Hazardous materials teams secured the location in northeast Las Vegas near Washington Avenue and Hollywood Boulevard, uncovering refrigerators containing vials of unknown liquids that raised immediate biosecurity concerns.

California Biolab Discovery Reveals Disturbing Conditions

The origins of this investigation trace back to December 18, 2022, when Reedley Code Enforcement received a complaint about unpermitted plumbing at what appeared to be a warehouse. Officials who accessed the facility the next day discovered far more than building code violations. Inside, they found test kit packaging operations, manufacturing equipment, blood and tissue serums, and approximately 1,000 transgenic mice kept in inhumane, overcrowded conditions. These genetically engineered mice were allegedly designed to model human COVID-19 infection for research purposes, yet operated without proper permits, oversight, or animal welfare protections.

The Reedley facility exemplifies the dangers of unregulated foreign-linked operations exploiting gaps in federal and state oversight. Fresno County Public Health officials documented the presence of blood, tissue, and bodily fluids stored in unsanitary conditions, creating potential biohazard risks for nearby communities. Zhu deliberately misled federal regulators by lying about his identity and involvement when questioned by the FDA, demonstrating a calculated effort to evade accountability while continuing to profit from fraudulent medical products sold to unsuspecting Americans during a national health crisis.

Biosecurity Risks Demand Immediate Action

Clark County Sheriff Kevin McMahill publicly stated there was no immediate threat to the public, describing the situation as an isolated incident. However, the arrest of an unidentified property manager on the day of the raid, combined with the ongoing presence of hazardous materials teams, suggests authorities are taking the threat seriously. The Joint Terrorism Task Force’s involvement indicates federal agencies recognize the national security implications of clandestine biological operations run by foreign nationals using false identities and operating through shell companies designed to obscure ownership and evade regulatory scrutiny.

This case exposes critical vulnerabilities in America’s diagnostic testing supply chain and biosecurity infrastructure that flourished under previous policies prioritizing globalism over national sovereignty. The ease with which Zhu and Wang established multiple unauthorized facilities across California and Nevada, manufactured hundreds of thousands of fraudulent medical devices, and continued operations even after initial discovery demonstrates how weak enforcement emboldens bad actors. President Trump’s administration now faces the task of closing regulatory gaps that allowed Chinese-linked entities to operate illegal biolabs in residential neighborhoods, endangering public health while profiting from American consumers’ trust during a pandemic.